A response weighing why STRIDE-II targets are harder to hit in everyday practice.
Saudi Journal of GastroenterologySaudi J Gastroenterol. 2026; 32(5); pp. 451-452
Mohammed Nabil Quraishi
SGA Briefing
A reply addressing how treat-to-target assessment, healthcare access, and service design shape real-world achievement of STRIDE-II goals in inflammatory bowel disease.
Read the full article
This links to the publisher’s open-access copy of record. A self-hosted PDF will appear here once one is on file.